Peipei Xu

3.2k total citations
159 papers, 2.2k citations indexed

About

Peipei Xu is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Peipei Xu has authored 159 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 40 papers in Oncology and 35 papers in Hematology. Recurrent topics in Peipei Xu's work include Multiple Myeloma Research and Treatments (17 papers), Acute Myeloid Leukemia Research (13 papers) and Nanoplatforms for cancer theranostics (12 papers). Peipei Xu is often cited by papers focused on Multiple Myeloma Research and Treatments (17 papers), Acute Myeloid Leukemia Research (13 papers) and Nanoplatforms for cancer theranostics (12 papers). Peipei Xu collaborates with scholars based in China, United States and Australia. Peipei Xu's co-authors include Jian Ouyang, Da Huo, Yong Hu, Yu‐qiang Ma, Ruju Wang, Huaqin Zuo, Donglin Xia, Bing Chen, Hong‐Ming Ding and Xiang Lu and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Peipei Xu

147 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peipei Xu China 24 800 576 372 339 315 159 2.2k
Hirokazu Miki Japan 21 508 0.6× 501 0.9× 368 1.0× 327 1.0× 195 0.6× 81 1.6k
Tao Lu China 25 1.0k 1.3× 479 0.8× 160 0.4× 426 1.3× 247 0.8× 116 2.4k
Elizabeth S. Ingham United States 26 908 1.1× 783 1.4× 456 1.2× 477 1.4× 178 0.6× 50 2.5k
David M. Weinreich United States 20 685 0.9× 427 0.7× 374 1.0× 453 1.3× 261 0.8× 32 2.8k
Thomas Mueller Germany 34 1.0k 1.3× 636 1.1× 550 1.5× 650 1.9× 139 0.4× 113 3.1k
Qin Lu China 32 1.2k 1.5× 875 1.5× 732 2.0× 399 1.2× 465 1.5× 106 3.0k
Simon Zhou United States 22 754 0.9× 391 0.7× 296 0.8× 498 1.5× 212 0.7× 71 2.5k
Weiqi Lu China 26 886 1.1× 161 0.3× 293 0.8× 448 1.3× 345 1.1× 120 2.5k
Mathumai Kanapathipillai United States 18 629 0.8× 776 1.3× 493 1.3× 241 0.7× 162 0.5× 34 1.8k
Xiaodong Xie China 32 1.7k 2.1× 506 0.9× 375 1.0× 625 1.8× 300 1.0× 141 3.2k

Countries citing papers authored by Peipei Xu

Since Specialization
Citations

This map shows the geographic impact of Peipei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peipei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peipei Xu more than expected).

Fields of papers citing papers by Peipei Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peipei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peipei Xu. The network helps show where Peipei Xu may publish in the future.

Co-authorship network of co-authors of Peipei Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Peipei Xu. A scholar is included among the top collaborators of Peipei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peipei Xu. Peipei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Kezhen, et al.. (2024). Multi-ion detection chemosensor based on rhodamine for turn-on fluorescence sensing and bioimaging of Fe3+, Al3+, Cr3+, and Hg2+ under different channels. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 318. 124484–124484. 17 indexed citations
3.
Xu, Peipei, et al.. (2024). Design of an intelligent Near-Infrared responsive antibacterial Nano-Platform based on MoS2/Cu3Mo2O9. Chemical Engineering Journal. 496. 154078–154078. 5 indexed citations
4.
Wang, Nan, et al.. (2024). Principle of vanadium doping-induced MoS2 homojunction effect and mechanism analysis of antibacterial process under near-infrared light. Separation and Purification Technology. 356. 129814–129814. 1 indexed citations
5.
Wang, Haonan, Peipei Xu, Yi‐Ting Chen, et al.. (2024). “Partner” cellulose gel with “dialysis” function: Achieve the integration of filtration-enrichment-SERS detection. Biosensors and Bioelectronics. 267. 116775–116775. 7 indexed citations
7.
Wang, Lei, et al.. (2024). Design of Onboard Avionics Based on Commercial Off-the-Shelf Parts for TianQi-2 Nanosatellite. Journal of Spacecraft and Rockets. 61(4). 1114–1123. 1 indexed citations
8.
Xu, Peipei, et al.. (2024). Onboard Avionics in the New Space Era: Present and Future. Journal of Aerospace Information Systems. 21(9). 761–774.
9.
Tan, Yang, Zhibo Zhao, Qingfang Han, et al.. (2024). Identification of an RNA-binding perturbing characteristic for thiopurine drugs and their derivatives to disrupt CELF1–RNA interaction. Nucleic Acids Research. 52(18). 10810–10822.
10.
Cui, Lu, Juan Xu, Peipei Xu, et al.. (2024). Epidemiological Characteristics of Fracture Among Children Aged 6–17 Years — China, 2019–2021. China CDC Weekly. 6(32). 799–803. 1 indexed citations
11.
Zhou, Tong, Yonggong Yang, Peipei Xu, et al.. (2024). Diagnostic performance of metagenomic next-generation sequencing among hematological malignancy patients with bloodstream infections after antimicrobial therapy. Journal of Infection. 90(2). 106395–106395. 2 indexed citations
12.
Xu, Peipei, Gang Zhao, Gang Wei, et al.. (2023). A novel POSS-based nanoplatform for repairing of poisoning cells and its application in tracking and detoxification of Hg2+ in vivo. Chemical Engineering Journal. 477. 146798–146798. 2 indexed citations
13.
Yang, Nanfei, Bing Chen, Yuncheng Bei, et al.. (2023). A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy. Acta Pharmaceutica Sinica B. 13(7). 3027–3042. 12 indexed citations
14.
Li, Chenming, et al.. (2023). A novel dimensionality reduction algorithm for Cholangiocarcinoma hyperspectral images. Optics & Laser Technology. 167. 109689–109689. 9 indexed citations
15.
Bai, Hua, et al.. (2020). PLP2 Expression as a Prognostic and Therapeutic Indicator in High‐Risk Multiple Myeloma. BioMed Research International. 2020(1). 4286101–4286101. 6 indexed citations
16.
Xu, Peipei, et al.. (2019). Higher single dose of bortezomib plus thalidomide and dexamethasone is a promising therapy for newly diagnosed multiple myeloma. Translational Cancer Research. 8(5). 2099–2106. 2 indexed citations
17.
Zuo, Huaqin, et al.. (2018). Prognostic significance of neutrophil-lymphocyte ratio in multiple myeloma patients. Translational Cancer Research. 7(1). 88–96. 3 indexed citations
18.
Xu, Peipei, et al.. (2017). The association between expression of hypoxia inducible factor-1α and multi-drug resistance of acute myeloid leukemia. Translational Cancer Research. 6(1). 198–205. 5 indexed citations
19.
Xu, Peipei, Baoan Chen, Jifeng Feng, et al.. (2012). Polymorphisms in XPC provide prognostic information in acute myeloid leukemia. International Journal of Hematology. 96(4). 450–460. 11 indexed citations
20.
Li, Xiuyu, et al.. (2012). Study of Diel Vertical Migration patterns of zooplankton during different seasons in Jiaozhou Bay. Acta Oceanologica Sinica. 34(3). 146–154. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026